Why the study?
Does hyperkalemia reduce myocardial digoxin uptake and its inotropic effect in normal dogs?
Does hyperkalemia reduce myocardial digoxin uptake and its inotropic effect in normal dogs?
Hyperkalemia competitively antagonizes myocardial uptake of digoxin, leading to reduced tissue concentrations and a blunted inotropic effect despite elevated serum digoxin levels.
Answers are grounded in this paper and cite their sources.
Hyperkalemia may blunt digoxin effects despite high serum levels; leaves open translation to human HF management.
The effects of hyperkalemia on serum and myocardial digoxin (DX) concentration was studied in conjunction with hemodynamic changes in 31 normal dogs. The myocardial DX concentration in the hyperkalemic (HK) group was significantly lower than that in normokalemic (NK) group, despite a significantly higher serum DX concentration in the HK group. In the HK group, the myocardial sodium concentration was significantly lower than in the NK group. Coincident with these biochemical changes, no increase of LV max dP/dt after DX administration was observed in the HK group. These results suggest that there might be competitive antagonism between myocardial uptake of potassium and DX.
No takes yet. Share an insight, caveat, or question.
Kori et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: